Board of Directors

Thomas Loarie
Chairman of the Board

Thomas Loarie joined Refocus Group in 2014 and now serves as the Chairman of Board of Directors. With his extensive Class III medical device experience, he assists the board and executive team in the clinical development and commercialization of VisAbility™ Micro-Insert System for presbyopia.

Mr. Loarie is also the Co-founder and CEO of BryoLogyx, Inc. He has over 45 years in the healthcare industry that includes 30+ years leading venture-backed healthcare start-ups and 13 years with American Hospital Supply Corp (now Baxter), where he was president of the American Heyer-Schulte Division. He also has global operating and commercialization experience and has brought more than 20 innovative products to market across 11 healthcare domains. Mr. Loarie formerly served as assistant professor of surgery at Creighton University, and currently serves on the Dean’s Advisory Council of the Jacobs School of Engineering at University of California at San Diego.

He has a B.S.M.E. from the University of Notre Dame, and attended graduate school at the Universities of Minnesota and Chicago.

Mike Judy

Mike Judy joined Refocus Group in 2013 as the Chief Executive Officer, bringing with him 30 years of experience in the ophthalmology industry. Prior to joining Refocus, he most recently served as Chief Commercial Officer for AcuFocus, leading the sales and marketing team as they introduced the KAMRA™ corneal inlay.

Mr. Judy’s previous experience also includes his role as the Vice President of Global Surgical Marketing for Bausch and Lomb, where he was responsible for the cataract and refractive businesses. He joined B&L through the acquisition of Eyeonics, manufacturer of the Crystalens®. At Eyeonics, Mr. Judy led the sales and marketing team that captured the number one market share position in the premium IOL market. He has also served on various industry boards throughout his career.

Mr. Judy has a BA from Princeton University.

Harry Jacobson, MD

Dr. Harry Jacobson has been a director of Refocus Group since 2011. His background is rich with medical, academic, and investment experience, giving him unique insight to contribute to the Refocus board. He is currently the Founder and Managing Partner of the Health Care Investment Group.

Previously, Dr. Jacobson was a cofounder of the dialysis services company Renal Care Group. Currently, He serves on the boards of Merck, Kinetic Concepts, and Ingram Industries. He spent 7 years on the faculty at University of Texas Southwestern and 25 years at Vanderbilt University. From 1997 to 2009, Dr. Jacobson led the Vanderbilt University Medical Center as the Vice Chancellor for Health Affairs. He also published more than 100 scientific papers, edited a major textbook in Nephrology, and served 2 years as a physician in the Army’s burn unit at Fort Sam Houston. In 2002, Dr. Jacobson’s was elected to the National Academy of Science’s Institute of Medicine for his contributions to medicine.

Dr. Jacobson has an MD from the University of Illinois, completed his medical residency at Johns Hopkins, and received specialty training in Nephrology at UT Southwestern Medical Center.

Thomas Lyles, Jr.

Thomas Lyles has served as Director of Refocus Group since 2005. As a member on a number of boards within the health care industry, he brings a solid legal and investment background to Refocus Group. In addition to his position on the Refocus board, Mr. Lyles serves as an advisory director to Majesty Hedge Funds, and sits on the boards of CeloNova BioSciences, Ambulatory Services of America, digiChart, MedSolutions, Informatics Corporation of America, and Outpatient Imaging Affiliates.

Mr. Lyles has served as president (since 1998) and general counsel (since 1990) of Mission City Management, where he has managed a multi-company investment portfolio, including public and large private companies. From 1984 to 1989, he was a senior associate with the law firm Haynes and Boone. Prior to attending law school, Mr. Lyles was an accountant with KPMG.

Mr. Lyles received his JD from SMU Law School in 1983 and his degree in accounting from Texas A&M University in 1979.

Donald Phillips

Mr. Phillips has over 34 years
of investment management experience managing
large pools of pension assets in
the capacity of both a limited and a general partner. Prior to founding WP
Global Partners in 2005, Mr. Phillips was the Chief Investment Officer and CEO
for WestAM (U.S.), a subsidiary of WestLB, a large German Bank. At WestAM he
directed the investment strategy and oversaw the firm’s approximately $3 billion
portfolio in commitments to private equity funds, real estate, and direct
investments. In addition, he was a member of WesAM’s Board of Directors. He
assumed these roles at WestAM in 2000 when they acquired the private equity
business of Forstmann-Leff International, Inc. Mr. Phillips had been President
of Forstmann-Leff from 1997 to 2000, and during that period was responsible for
the strategic process of building and managing the global investment management
firm. Forstmann-Leff International is a multi-asset class institutional
investment firm with offices in Chicago, New York, and Liverpool, England. The
firm has been managing assets for high net worth individuals, pension funds and
other institutions for almost 30 years with assets under management that exceed
$85 billion. The styles of managing assets include U.S. mid-cap value oriented
equities, fixed income that includes core U.S., high yield and global portfolio
management in addition to the management of private placement or alternative
asset classes for large institutions

From 1990 until 1997, Mr. Phillips
was Chairman of Equity Institutional Investors where he was responsible for the
formation of four real estate funds with equity commitments of over $2.5
billion. These funds have been subsequently consolidated into a public company,
Equity Office Properties that was sold to Blackstone for $50 billion in 2007.
During the same time period at Equity Group Investments, he was instrumental in
establishing the $1.1 billion Zell/Chilmark Fund to buy good companies with bad
balance sheets. The fund acquired seven public and private companies that have
combined sales of $8 billion and over 50,000 employees. Also, Mr. Phillips was
President of Capstone Holdings Corp., a publicly traded insurance holding
company and board member of other publicly traded companies within the Equity

His previous positions include eight years as the Chief
Investment Officer for Ameritech Corporation, where he managed all asset classes
of Ameritech’s $15 billion pension fund. The Ameritech fund was an early
investor in private equity, venture capital and commercial real estate. His
efforts at Ameritech were recognized by the Institutional Investor Magazine,
which sleected him as one of the country’s top 10 pension fund managers.
Recently, he was awarded the Richard J. Daley Medal by the Illinois Venture
Capital Association which recognizes “extraordinary contributions to the
Illinois Economy resulting from private equity investing.” He has an M.B.A. in
finance from Northern Illinois University and a B.A. in business from Western
Illinois University.